10/23/2025
A promising new clinical trial for women with recurrent ovarian cancer is underway at MUSC Hollings Cancer Center.
The trial—developed by Dr. Joe Delaney, Dr. Brian Orr, and supported by donor Matt Prisby—will test existing drugs already approved for other conditions, giving hope to patients who have few remaining options.
This “bench-to-bedside” collaboration shows how scientific innovation, compassionate care, and community support can change what’s possible in cancer treatment.
Learn more about how we're in cancer care:
A new clinical trial for women with recurrent ovarian cancer is an outgrowth of a long-term partnership between a researcher, a donor and physicians.